Cell Therapy

Facilitating Organoid Production for Biopharmaceutical Applications

Karen Weisinger, Ph.D.

Cell X Technologies

3D Printing

Exploring New Possibilities with 3D Printing of Pharmaceuticals

Thomas Kipping, Ph.D.

MilliporeSigma

Aqueous Cleaning

The Power of Aqueous Detergents in Critical Cleaning

Michael Moussourakis

Alconox Inc.

Artificial Intelligence

Artificial Intelligence in Pharma, As Told by Artificial Intelligence

Pharma's Almanac

Pharma's Almanac

Big Data

Leveraging Big Data, Artificial Intelligence, and Machine Learning for Drug Discovery, Development, Manufacturing, and More

Cynthia A. Challener, Ph.D.; David Alvaro, Ph.D.

Pharma's Almanac

Manufacturing Investment

MilliporeSigma Announces Investment of More Than € 130 Million to Strengthen Manufacturing Capabilities in Molsheim, France

MilliporeSigma

M&A

Sartorius to Acquire Albumedix, Creating a Powerhouse for Innovative Advanced Therapy Solutions

Albumedix

Quantum Computing

Quantum Computing will Transform Drug Discovery, Development, Manufacturing, and Supply Chain Management

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Used Equipment

Guide to Resource Recovery for Fortune 500 Companies

Julie Meno

Federal Equipment Company

Virginia

Manufacturing Opportunities in Virginia

West Virginia Department of Economic Development

Vaccine and Cell & Gene Therapies

Expanding Manufacturing Capacity to Meet Market Demand for Vaccines and Cell and Gene Therapeutics

Prof. Dr. Ulrike Fiedler

IDT Biologika

GMP

Intravacc Announces the Publication of a GMP Process for a Semi-Synthetic Shigella Glycoconjugate Vaccine Candidate from Institut Pasteur

Intravacc

Drug Development

Advancing Drug Development with Emerging Technologies

Lonza

Manufacturing Training

Providing Equipment and Training for Growth in Pharma Manufacturing

Federal Equipment Company

Manufacturing Authorization

Vetter’s New Clinical Manufacturing Site Now Officially Authorized

Vetter

Sale

Arranta Bio Announces Completion of Sale of Florida Site and Progress on $150M Investment Plan to Expand Development and Commercial Manufacturing Services

Arranta Bio

Expansion

AGC Biologics Expands pDNA and mRNA Manufacturing Capacity at Heidelberg Facility

AGC Biologics

Sustainability

Olon Presents Its New Sustainability Manifesto

Olon Spa

3D Printing

Transferring 3D Printing into Pharma: The Journey Has Begun

Thomas Kipping, Ph.D.

MilliporeSigma

Cannabis

Resolving Cannabis Cleaning Challenges

Michael Moussourakis

Alconox Inc.